UNSPSC 51351522: Chlormadinone acetate

This classification denotes a therapeutic progestin with the molecular formula C23H29ClO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0SY050L61N, chemically known as 17.alpha.-acetoxy-6-chloro-4, 6-pregnadiene-3,20-dione but more generally known as chlormadinone acetate, which bears US NIH Compound Identifier 2714. European Medicines Agency schedules Chlormadinone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01219MIG.

I cannot write a meaningful summary for this UNSPSC code based on the source provided. The source contains only the code number, its chemical name (Chlormadinone acetate), and the tier designation—no block of recent state and local contract opportunities, no issuing bodies, no representative solicitations, and no geographic data. Without a <most-recent-state-local-contract-opportunities> block populated with actual procurement records, I cannot ground the summary in what state and local governments are actually buying, which is the core requirement for this format.

A pharmaceutical commodity code at this granularity (51351522, a progestin active pharmaceutical ingredient) would typically see limited state and local procurement activity outside of specialized contexts such as public health departments, correctional health services, or Medicaid-administered family planning programs. To write a useful summary, I would need recent solicitations from those jurisdictions—notice type, issuing body, response date, and scope—which the source does not provide.

If you have recent opportunities data for this code, provide it in the <most-recent-state-and-local-contract-opportunities> block and I will write the summary.